Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

OptimizeRx Corporation - Common Stock (NQ:OPRX)

21.41 +1.82 (+9.29%)
Streaming Delayed Price Updated: 12:08 PM EDT, Oct 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about OptimizeRx Corporation - Common Stock

< Previous 1 2 3 Next >
OptimizeRx Sets Third Quarter 2025 Conference Call for November 6, 2025, at 4:30 p.m. ET
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx to Participate in the 9th Annual Lake Street Capital Best Ideas Growth Conference
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Partners with Lamar Advertising to Reach Clinically Relevant Audiences Through Out-of-Home Healthcare Advertising
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Corporation Announces Leadership Team Advancements to Accelerate Strategic Growth
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Reports Second Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Sets Second Quarter 2025 Conference Call for August 7, 2025, at 4:30 p.m. ET
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Corporation Appoints CEO Steve Silvestro to Board of Directors
From OptimizeRx Corporation
Via GlobeNewswire
Simulmedia and OptimizeRx Announce Partnership from the Cannes Lions
From Simulmedia
Via Business Wire
OptimizeRx to Participate in Upcoming Investor Conferences
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Reports First Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Releases 2025 Environmental, Social, and Governance (ESG) Report
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Sets First Quarter 2025 Conference Call for May 12, 2025, at 4:30 p.m. ET
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Corporation Announces Plan for Additional Board of Directors Refreshment
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Reports Strong Fourth Quarter and Full Year 2024 Financial Results
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Corporation Confirms Receipt of Notice of Director Nominations
No Stockholder Action Required at this Time 
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Corporation Appoints Stephen Silvestro as Chief Executive Officer
Silvestro has a demonstrated record of accelerating revenue growth, expanding brand relevance, and building a market-leading team 
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Sets Fourth Quarter and Full Year 2024 Financial Results Conference Call for March 12, 2025, at 8:30 a.m. ET
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Announces Departure of CEO William Febbo and Appointment of Stephen Silvestro as Interim CEO
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx to Participate in Upcoming Investor Conferences
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Reports Third Quarter 2024 Financial Results
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Sets Third Quarter 2024 Conference Call for November 13, 2024 at 4:30 p.m. ET
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Continues to Expand its Strategic Relationship with a Top-Tier Pharma Client via a Multi-Brand, Multi-Solution Investment Commitment with Over $10M In-Year Total Value
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Launches Novel Brand Eligibility Technology, Enabling Dynamic Direct to Consumer Marketing for Healthcare Audiences
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Reports Second Quarter 2024 Financial Results
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Sets Second Quarter 2024 Conference Call for August 8, 2024 at 4:30 p.m. ET
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Delivers AI-Guided Privacy-Compliant Platform for Pharmaceutical Brand Marketing Amid Evolving Consumer Privacy Legislation
OptimizeRx Micro Neighborhood® Targeting enables pharmaceutical brands to maintain and expand campaign scale nationwide 
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Demonstrates Measurable Script Lift for a Major Depressive Disorder Brand Targeting Physicians of Hard-to-Reach Patients
The Company’s AI-guided predictive targeting platform delivered three times the return in half the time of the traditional trigger-based program 
From OptimizeRx Corporation
Via GlobeNewswire
New White Paper Highlights How Closing the Health Information Gap Between Doctors and Patients Improves Life Science Marketing & Adds Value to Clinical Conversations
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Reports First Quarter 2024 Financial Results
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx to Participate in Upcoming Investor Conferences
From OptimizeRx Corporation
Via GlobeNewswire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.